Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Zicam® Launches New Cold Remedy Nasal Spray
  • USA - English


News provided by

Protagonist LLC

Oct 30, 2014, 12:20 ET

Share this article

Share toX

Share this article

Share toX

Bridgewater, NJ (PRWEB) October 30, 2014 -- In a major expansion of its cold remedy product line, Bridgewater, N.J. based Matrixx Initiatives, Inc. has launched a new cold-shortening Nasal Spray with symptom relief under its popular Zicam® Cold Remedy Brand. The No Drip Nasal Spray complements Zicam’s bestselling oral cold shortening products and will be available nationally in time for the upcoming cold season.

Zicam Cold Remedy Nasal Spray is being supported by a robust national advertising campaign that includes television, radio, and digital. The television ads again feature the Cold Monster as Zicam’s bumbling nemesis, demonstrating how Zicam empowers consumers to shorten their colds and move on with their busy lives. Television flights began in October on the nationally syndicated reruns of number one hit “The Big Bang Theory”. In a major shift to its media strategy, Matrixx has shifted the bulk of its media buying from the upfront television market to a blend of programmatic buying, the latest innovation in media targeting.

While most cold treatments simply provide temporary symptom relief, Zicam Cold Remedy Nasal Spray actually shortens the length of the cold. In addition to shortening a cold, Zicam Cold Remedy Nasal Spray is clinically proven to reduce cold symptoms by up to 45% by the midpoint of a cold when taken as directed. Zicam, the leader in cold shortening is known for form, function and flavor innovation in the category.

“We’re truly excited to be launching Zicam Cold Remedy Nasal Spray” commented M’lou Arnett, CEO of Matrixx. “We haven’t had a nasal cold shortening solution for cold-sufferers since 2009 when we removed our zinc based nasal spray from the market, and we have been working hard to develop an exciting and effective product ever since. And we’re thrilled with the result. The plant derived active ingredients in this new nasal spray make it different from zinc based cold shortening remedies. With the added benefit of symptom reduction, consumers now have real choice when looking for clinically proven cold shortening solutions.”

Ms. Arnett added, “We know from past experience and from research that many consumers prefer a product that’s delivered right to the nose – the source of their cold suffering. We’re delighted to answer the call and ‘return to the nose’ with our famous cold shortening benefit in a unique homeopathic formula that is unlike any product we’ve ever sold.”

It’s estimated that Americans suffer 1 billion colds each year. Zicam has been at the forefront of cold season management for decades. As the leading cold shortening brand, Zicam offers a wide range of products to shorten colds or manage symptoms. Zicam’s new Cold Remedy Nasal Spray is the only clinically proven cold shortening nasal spray and one of a handful of products on the market today that provides cold shortening with symptom relief. That makes it a truly progressive solution for consumers.

“With a large percentage of our consumer base active women, our advertising will reflect how a cold isn’t something that has to get in the way of her daily routine” commented Lori Norian, Vice President of Marketing for Zicam. “She’s the one everyone depends upon to get things done, and we’ve added a bit of levity in our Cold Monster ads this year to show how easily she can knock the Cold Monster for a loop with the multiple benefits of the new Nasal Spray and reduce its impact on her happy and busy life,” added Norian.

Matrixx Initiatives, Inc., has been engaged in the development and marketing of better ways to feel better through over-the-counter health care products that utilize innovative drug delivery systems for over 20 years. The Zicam® portfolio includes cold remedy, cough relief, nasal decongestant and allergy relief products.
***

About Zicam® Cold Remedy Products
While most cold medicines are designed just to mask cold symptoms, ZICAM® Cold Remedy is COMPLETELY DIFFERENT®. ZICAM® Cold Remedy oral products, which contain proprietary formulations of active ingredients zinc gluconate and zinc acetate, reduce the duration of a cold when taken at the first sign of a cold (within the first 24 hours) and used as directed. ZICAM® Cold Remedy nasal spray contains a patented formulation of galphimia glauca, luffa operculata and sabadilla to reduce the duration and severity of a cold when taken at symptom onset and used as directed. ZICAM® Cold Remedy is for a PRE-COLD®, that first sniffle, sneeze or ache that signals that a full-blown cold is coming.

About Matrixx Initiatives, Inc.
Matrixx Initiatives, Inc. has been engaged in the development and marketing of better ways to feel better through over-the-counter health care products that utilize innovative drug delivery systems for over 20 years. Acquired by HIG Capital in February 2011, Matrixx Initiatives manufactures and markets ZICAM® brand homeopathic and allopathic OTC products, including its clinically proven line of ZICAM® Cold Remedy Nasal Spray, ZICAM® Cold Remedy RAPIDMELTS® and Ultra RAPIDMELTS ® and ZICAM® Cold Remedy Oral Mist™, as well as ZICAM® Allergy Relief, ZICAM® Extreme Congestion Relief, ZICAM® Intense Sinus Relief, and ZICAM® Cold Remedy for Kids. For more information regarding Matrixx products, please visit http://www.zicam.com.

Protagonist, Protagonist LLC, http://beaprotagonist.com/, +1 508-989-7425, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.